You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood conditions
Active B12 assay for diagnosing vitamin B12 deficiency
Medtech innovation briefing
Reference number:
MIB40
Published:
30 September 2015
Download (PDF)
Overview
Summary
Introduction
Technology overview
Evidence review
Relevance to NICE guidance programmes
References
Search strategy and evidence selection
Appendix
About this briefing
Relevance to NICE guidance programmes
The use of Active‑B12 is not currently planned into any NICE guidance programme.
Next page
References
Previous page
Evidence review
Back to top